2017 Q2 Form 10-Q Financial Statement

#000114420417027024 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q1
Revenue $1.210M $1.007M $568.0K
YoY Change 80.87% 77.29% 747.76%
Cost Of Revenue $850.0K $901.0K $670.0K
YoY Change 2.91% 34.48% 125.59%
Gross Profit $360.0K $106.0K -$102.0K
YoY Change -329.3% -203.92% -55.65%
Gross Profit Margin 29.75% 10.53% -17.96%
Selling, General & Admin $3.290M $3.840M $1.420M
YoY Change 68.72% 170.42% 115.15%
% of Gross Profit 913.89% 3622.64%
Research & Development $1.184M $470.0K $397.0K
YoY Change 127.26% 18.39% -55.04%
% of Gross Profit 328.89% 443.4%
Depreciation & Amortization $60.00K $43.00K $102.0K
YoY Change -33.33% -57.84% 29.11%
% of Gross Profit 16.67% 40.57%
Operating Expenses $4.478M $4.311M $1.821M
YoY Change 81.59% 136.74% 17.71%
Operating Profit -$4.118M -$4.205M -$1.923M
YoY Change 57.0% 118.67% 8.22%
Interest Expense $8.680M -$1.210M -$440.0K
YoY Change -706.99% 175.0% -414.29%
% of Operating Profit
Other Income/Expense, Net $26.00K -$1.208M $734.0K
YoY Change -101.81% -264.58% 428.06%
Pretax Income $4.570M -$5.410M -$2.360M
YoY Change -212.56% 129.24% 43.9%
Income Tax
% Of Pretax Income
Net Earnings -$4.092M -$5.413M -$1.189M
YoY Change 0.86% 355.26% -27.41%
Net Earnings / Revenue -338.18% -537.54% -209.33%
Basic Earnings Per Share
Diluted Earnings Per Share $7.746M -$15.03M -$9.077M
COMMON SHARES
Basic Shares Outstanding 9.582M shares 7.977M shares 53.50M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.100M $3.100M $8.300M
YoY Change -35.94% -62.65% 336.84%
Cash & Equivalents $3.898M $2.817M $8.267M
Short-Term Investments $200.0K $200.0K $100.0K
Other Short-Term Assets
YoY Change
Inventory $700.0K $800.0K $1.000M
Prepaid Expenses
Receivables $400.0K $500.0K
Other Receivables $600.0K $700.0K
Total Short-Term Assets $5.862M $5.100M $10.20M
YoY Change -27.63% -50.0% 316.5%
LONG-TERM ASSETS
Property, Plant & Equipment $800.0K $900.0K $700.0K
YoY Change -20.0% 28.57% -25.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change
Total Long-Term Assets $873.0K $900.0K $800.0K
YoY Change -12.7% 12.5% -17.95%
TOTAL ASSETS
Total Short-Term Assets $5.862M $5.100M $10.20M
Total Long-Term Assets $873.0K $900.0K $800.0K
Total Assets $6.735M $6.000M $11.00M
YoY Change -25.99% -45.45% 221.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000M $1.500M $600.0K
YoY Change 0.0% 150.0% -25.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.800M $2.700M $1.489M
YoY Change 40.0% 81.33% -10.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00 $1.900M
YoY Change -100.0% -100.0% -51.28%
Total Long-Term Liabilities $0.00 $0.00 $1.900M
YoY Change -100.0% -100.0% -71.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.800M $2.700M $1.489M
Total Long-Term Liabilities $0.00 $0.00 $1.900M
Total Liabilities $2.800M $2.800M $3.400M
YoY Change -28.21% -17.65% -58.54%
SHAREHOLDERS EQUITY
Retained Earnings -$51.72M -$45.00M
YoY Change 14.93% 19.37%
Common Stock $6.000K $6.000K $6.000K
YoY Change 0.0% 100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.000M $3.233M $7.611M
YoY Change
Total Liabilities & Shareholders Equity $6.700M $5.985M $10.96M
YoY Change -26.37% -45.41% 220.18%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$4.092M -$5.413M -$1.189M
YoY Change 0.86% 355.26% -27.41%
Depreciation, Depletion And Amortization $60.00K $43.00K $102.0K
YoY Change -33.33% -57.84% 29.11%
Cash From Operating Activities -$2.750M -$3.083M -$2.110M
YoY Change 62.72% 46.11% 37.91%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K $0.00 $35.00K
YoY Change -85.71% -100.0% -2.78%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$10.00K $10.00K
YoY Change -100.0% -200.0% 0.0%
Cash From Investing Activities -$30.00K -$9.000K -$30.00K
YoY Change -86.36% -70.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.850M $4.816M 7.730M
YoY Change 19150.0% -37.7% 294.39%
NET CHANGE
Cash From Operating Activities -2.750M -$3.083M -2.110M
Cash From Investing Activities -30.00K -$9.000K -30.00K
Cash From Financing Activities 3.850M $4.816M 7.730M
Net Change In Cash 1.070M $1.724M 5.590M
YoY Change -156.61% -69.16% 1297.5%
FREE CASH FLOW
Cash From Operating Activities -$2.750M -$3.083M -$2.110M
Capital Expenditures -$30.00K $0.00 $35.00K
Free Cash Flow -$2.720M -$3.083M -$2.145M
YoY Change 83.78% 43.73% 36.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54945000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51718000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
3233000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5985000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3872000 USD
CY2016Q1 us-gaap Revenues
Revenues
568000 USD
CY2017Q1 us-gaap Revenues
Revenues
1007000 USD
CY2017Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
901000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
-102000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
106000 USD
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
670000 USD
CY2016Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
519000 USD
CY2017Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1825000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
905000 USD
CY2016Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
226000 USD
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1812000 USD
CY2016Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1113000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2925000 USD
CY2016Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7488000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48413000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54960000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-6541000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2017000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
1821000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4311000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1923000 USD
CY2016Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
432000 USD
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7460000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7447000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
3242000 USD
CY2016Q1 drio Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
455000 USD
CY2017Q1 drio Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
0 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2823000 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3242000 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.77
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.45
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3652474 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7195801 shares
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2277000 USD
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
605000 USD
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1572000 USD
CY2016 drio Stock Issued During Period Private Placement Value New Issues March2016
StockIssuedDuringPeriodPrivatePlacementValueNewIssuesMarch2016
828000 USD
CY2016 drio Issuance Of Common Stock In January2016 To Service Provider
IssuanceOfCommonStockInJanuary2016ToServiceProvider
37000 USD
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
310000 USD
CY2016 drio Stock Issued During Period Value Issued To Officer
StockIssuedDuringPeriodValueIssuedToOfficer
86000 USD
CY2016 drio Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
210000 USD
CY2016 drio Deemed Dividend Related To Change In Conversion Term Of Series Preferred Stock Value
DeemedDividendRelatedToChangeInConversionTermOfSeriesPreferredStockValue
0 USD
CY2016 drio Deemed Dividend Related To Exchange Agreement Adjustment
DeemedDividendRelatedToExchangeAgreementAdjustment
0 USD
CY2017Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1585000 USD
CY2016Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
324000 USD
CY2017Q1 drio Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
210000 USD
CY2016Q1 drio Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
-10000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-328000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-422000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3082000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2105000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-23000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
404000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-27000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9000 USD
CY2016Q1 drio Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
7538000 USD
CY2017Q1 drio Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
4816000 USD
CY2017Q1 drio Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
0 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7728000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4816000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5596000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1724000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2671000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8267000 USD
CY2016Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2277000 USD
CY2017Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2016Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
244000 USD
CY2017Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
262000 USD
CY2016Q1 drio Payments For Proceeds From Acquire Leases Held For Investment
PaymentsForProceedsFromAcquireLeasesHeldForInvestment
-8000 USD
CY2017Q1 drio Payments For Proceeds From Acquire Leases Held For Investment
PaymentsForProceedsFromAcquireLeasesHeldForInvestment
9000 USD
CY2016Q1 drio Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
190000 USD
CY2017Q1 us-gaap Depreciation
Depreciation
44000 USD
CY2016Q1 us-gaap Depreciation
Depreciation
102000 USD
CY2017Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
256000 USD
CY2016Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
CY2016Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
431000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
457000 USD
CY2017Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
425000 USD
CY2017Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
424000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1585000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
324000 USD
CY2016Q1 drio Bank Charges
BankCharges
-4000 USD
CY2017Q1 drio Bank Charges
BankCharges
-5000 USD
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9000 USD
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8000 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
DarioHealth Corp.
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001533998
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Trading Symbol
TradingSymbol
DRIO
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9582377 shares
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7976521 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7976521 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5713383 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5713383 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2016Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2017Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.75in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="72"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <b><font style="FONT-SIZE: 10pt">NOTE 3:-</font></b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><b><font style="FONT-SIZE: 10pt">UNAUDITED INTERIM FINANCIAL STATEMENTS</font></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt">The accompanying unaudited interim consolidated financial statements as of March 31, 2017, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of March 31, 2017, and the Company's consolidated results of operations and the Company's consolidated cash flows for the three months ended March 31, 2017. Results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017.&#160;</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5100000 USD
CY2017Q1 drio Stock Issued During Period Shares New Issues February2014
StockIssuedDuringPeriodSharesNewIssuesFebruary2014
1821437 shares
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-1580000 USD
CY2017Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
271000 USD
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1200000 USD
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
CY2017Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
482000 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q1 drio Stock Issued During Period Private Placement Value New Issues January2017
StockIssuedDuringPeriodPrivatePlacementValueNewIssuesJanuary2017
2886000 USD
CY2017Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
250000 USD
CY2017Q1 drio Issuance Of Common Stock In January2017 To Employees Value
IssuanceOfCommonStockInJanuary2017ToEmployeesValue
1198000 USD
CY2017Q1 drio Issuance Of Common Stock In January2017 To Consultants And Service Provider Value
IssuanceOfCommonStockInJanuary2017ToConsultantsAndServiceProviderValue
49000 USD
CY2017Q1 drio Stock Issued During Period Private Placement Value New Issues March2017
StockIssuedDuringPeriodPrivatePlacementValueNewIssuesMarch2017
1878000 USD
CY2017Q1 us-gaap Inventory Write Down
InventoryWriteDown
22000 USD
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
315000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7488000 USD
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-7460000 USD
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
28000 USD
CY2017Q1 drio Payment For Directors And Management Under Shares For Cash Program
PaymentForDirectorsAndManagementUnderSharesForCashProgram
183000 USD
CY2016Q1 drio Payment For Directors And Management Under Shares For Cash Program
PaymentForDirectorsAndManagementUnderSharesForCashProgram
51000 USD

Files In Submission

Name View Source Status
0001144204-17-027024-index-headers.html Edgar Link pending
0001144204-17-027024-index.html Edgar Link pending
0001144204-17-027024.txt Edgar Link pending
0001144204-17-027024-xbrl.zip Edgar Link pending
drio-20170331.xml Edgar Link completed
drio-20170331.xsd Edgar Link pending
drio-20170331_cal.xml Edgar Link unprocessable
drio-20170331_def.xml Edgar Link unprocessable
drio-20170331_lab.xml Edgar Link unprocessable
drio-20170331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v465191_10q.htm Edgar Link pending
v465191_ex31-1.htm Edgar Link pending
v465191_ex31-2.htm Edgar Link pending
v465191_ex32-1.htm Edgar Link pending
v465191_ex32-2.htm Edgar Link pending